Schedule 13G ownership disclosure

AVANOS MEDICAL, INC.

COMMON STOCK · CUSIP: 05350V106

Event date: 2025-03-31

Filing-level shares
3,757,576
Percent of class
8.2%
  • T. Rowe Price Investment Management, Inc.

    Shares: 3,757,576 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000204
Form type
SCHEDULE 13G/A
Filer
AVANOS MEDICAL, INC.
CIK
CIK 1606498
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub